“Usually, we sell our astaxanthin in the form of oleoresin and beadlets to dietary supplement manufacturers,” said Efrat Kat, marketing director at Israel-based Algatechnologies.
“But due to the increase in demand for our high-value AstaPure astaxanthin line from other manufacturers, who cannot produce the necessary initial quantities of softgels themselves, we decided to provide it in capsules as well.”
She said the company would not sell the capsules direct to consumers, only to business partners and would focus on Europe, the US and also in Asia Pacific.
The global astaxanthin market is estimated at about €190m globally, most of which is used in fish colouration. The human uses market is estimated at about €20-€30m.